Laminin 511 Product List
You Have Viewed 0 Of 0 Results
Clinical Drug Information
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| TTX-030 | TTX-030 | Phase 2 Clinical | Adimab LLC | Solid tumours; Pancreatic Neoplasms; Lymphoma | Details |
| IPH-5201 | IPH-5201 | Phase 2 Clinical | Inserm, Orega Biotech | Solid tumours; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| Perenostobart | SRF-617 | Phase 2 Clinical | Surface Oncology Inc | Solid tumours; Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms | Details |
| JS-019 | JS-019 | Phase 1 Clinical | Beijing Enrini Biotechnology Co Ltd | Solid tumours; Eosinophilia; Lymphoma | Details |
| ES-014 | ES-014 | Phase 1 Clinical | Solid tumours; Neoplasms; Neoplasm Metastasis | Details | |
| PUR-001 | PUR-001 | Phase 1 Clinical | Purinomia Biotech Inc | Solid tumours | Details |
| AB-598 | AB598 | Phase 1 Clinical | Arcus Biosciences Inc | Ovarian Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck; Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | Details |
| Eurestobart | ES-002023 | Phase 1 Clinical | Solid tumours | Details | |
| ES-002 | ES-002 | Phase 1 Clinical | Solid tumours; Neoplasms | Details |